Clinical trial

Extreme Challenges - Psychopathology & Treatment Experiences Among Severly Selfharming Inpatients in Norway

NCT03768674

Study summary

ClinicalTrials.gov

Extreme Challenges - Psychopathology & Treatment Experiences Among Severly Selfharming Inpatients in Norway

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Assessment of diagnoses, functioning and health services Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2019-10-01

PhaseN/A

Conditions

Self Harmunresolved

Personality Disordersunresolved

Psychosisverified · MONDO: psychotic disorder

Developmental Disorderunresolved

PTSDverified · MONDO: post-traumatic stress disorder

Cognitive Impairmentunresolved

Interventions

Assessment of diagnoses, functioning and health servicesOTHER

Sponsors & collaborators

Oslo University Hospitallead sponsor

Extrastiftelsencollaborator

National Advisory Unit for Personality Psychiatry (NAPP)collaborator

Research Group Personality Psychiatrycollaborator

Network for personality-focused treatmentcollaborator

National Centre for Suicide Research and Prevention (NSSF)collaborator

Regional Centre for Violence and Traumatic Stress (RVTS)collaborator

Regional Centre for Early Intervention Psychosis (TIPS SØrØst)collaborator

Regional collaborators and userscollaborator

Mapped research locations

OsloNorway1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03768674 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.